|
GLAUCOMA - a patient's guide
Dr Peter Ring - Eye Surgeon
Overview
Glaucoma is a pressure build up in the eye which damages
the optic nerve
The nerve damage creates blind areas in the peripheral
vision
The condition can lead to tunnel vision and eventually
blindness
Glaucoma mainly affects older people over the age of 40
Afro-Americans and people who are short-sighted are at
higher risk
People over the age of 40 should have their vision checked
every three years
Glaucoma can not be cured but treatment can stop its progression
to blindness
Treatment includes eye drops, medication, and surgery
What is Glaucoma?
The front part of the eye is filled with a fluid called
aqueous humor. Its production and drainage out of the eye
are controlled so the eye is maintained within a normal
pressure range (the intra-ocular pressure). If the aqueous
is prevented from draining properly the pressure builds
up in the eye and this can damage the optic nerve. This
is known as glaucoma.
The optic nerve carries the images we see from the retina
to the brain and is like an electric cable containing about
one million wires. When these nerves become damaged in glaucoma,
blind areas in our peripheral vision are created and if
the damage continues the visual field becomes smaller leading
to tunnel vision and eventually blindness.
Types of Glaucoma
Primary open angle glaucoma (POAG):
This is by far the most common type of glaucoma affecting
1-2% of the population. The following discussion all relates
to this type of glaucoma.
Acute closed angle glaucoma:
This occurs when there is sudden blockage of the drainage
canal resulting in a rapid pressure build-up, halos around
lights and a very severe headache.
Normal or low tension glaucoma:
Some people can experience visual loss from glaucoma despite
having a normal intraocular pressure. It is felt that this
is due to poor blood supply to the optic nerve at the back
of the eye and indeed this may play a part in POAG as well.
Ocular hypertension:
Some people with high intraocular pressure never develop
the optic nerve damage of glaucoma. These people still need
to be followed carefully by an ophthalmologist.
Congenital glaucoma:
Very rarely glaucoma occurs within the first few years
of life.
Secondary glaucoma:
The high intraocular pressure may be due to some process
going on inside the eye such as inflammation, injury etc.
Who is at risk?
POAG very rarely comes on under the age of 40 and becomes
more frequent with increasing age. If there is a family
history of this condition, there is a 10% increased risk
for other members of the family. Afro-Americans have a higher
risk than Caucasians. Myopic or short-sighted people also
tend to have a slightly higher incidence.
What are the symptoms?
There are none. This is why glaucoma is so nasty in that
it is a silent disease. By the time a person notices their
peripheral vision has been affected, the disease is already
at a very advanced stage. Because glaucoma affects the peripheral
vision, a patient with glaucoma will have normal sight (even
with tunnel vision) until just before they go blind. POAG
does not give rise to headaches, "pressure around the eyes",
red eyes, irritation and soreness etc.
How is it diagnosed?
Every person over the age of 40 should have their eyes
checked about every three years. During this process the
intraocular pressure is measured to see that it is within
normal limits and the optic nerve at the back of the eye
is examined for any evidence of damage. If there is any
suspicion, the patient's visual field is examined on an
instrument called a perimeter. This involves sitting in
front of a bowl shaped screen looking straight ahead and
pushing a button whenever pinpoints of light are shown into
their visual field above, below and to the side.
Monitoring glaucoma
Usually the intraocular pressures are measured every six
months and the visual fields tested annually, but obviously
this may vary with each individual case.
Can glaucoma be cured?
No. But it can be controlled so that further damage to
the optic disc and visual field does not occur. For POAG
this means a lifelong commitment to treatment and regular
checks.
Treatment of glaucoma
There are many treatment options for glaucoma including
eyedrops, tablets, laser treatment and drainage filtering
surgery.
Glaucoma eye drops:
This is the first line of treatment as it is the safest
and easiest option. But they must be taken regularly and
probably for the rest of the patient's life. Until three
years ago there were only three types of drops available
in New Zealand, but more recently three other types of drops
have also become available. Some of these drops work by
decreasing the production of aqueous humor and others increase
the outflow. Some of the drops need only be used once a
day while others may need to be used two or four times daily.
Initially a patient is put on one type of drop which will
bring the intraocular pressure down. Over a period of time
however the pressure may creep up again and additional types
of drops may have to be used as well. However, if the glaucoma
worsens despite using drops, then surgery may be needed.
Like all medication, the drops have certain side effects
and some may be contraindicated in some people. Asthma is
a contraindication to one type of anti-glaucoma drops.
Tablets:
These are very rarely used these days because the drops
are more efficient and the tablets tend to have unpleasant
side effects.
Laser treatment:
In simple terms, a trabeculoplasty opens the clogged drainage
holes with a laser. This treatment is not commonly done
and not every case of POAG is suitable. Overseas studies
also show that any pressure drop achieved is not long lasting.
Glaucoma surgery:
This involves creating a new channel for the fluid to
drain out of the eye and is known as a trabeculectomy.
When is surgery indicated?
Surgery for glaucoma is indicated if the pressure is not
under adequate control and the visual field is getting progressively
worse despite all the drops being taken.
How is the surgery done?
Nowadays surgery is most commonly done under local anaesthesia
and on an outpatient basis. Under the upper lid a small
flap is made in the sclera or white part of the eye. A small
hole is made underneath this flap and the aqueous humor
diffuses out underneath the conjunctiva to form a small
blister or bleb.
What are the risks of surgery?
Like all operative procedures, there is a risk of infection,
but this is extremely rare and usually quite treatable.
Successful surgery requires just the correct amount of fluid
draining out of the eye and this can be difficult to achieve.
In the immediate post-operative period, too much fluid may
drain out and this can lead to problems. In the longer term
the body's healing processes may scar over the drainage
site and the operation may ultimately fail. The patient
then has to go back on drops but the procedure can be repeated.
Also in the long term, there is a higher incidence of cataracts
(clouding of the lens) occurring in patients who have had
trabeculectomies.
Management after surgery
Depending on how successful the drainage procedure has
been, drops may or may not be still required. No matter
how successful the surgery may be, ongoing regular checks
are still required for the rest of the patient's life.
Other surgical procedures
In advanced complicated glaucoma there is a procedure
whereby a little plastic tube is put into the front of the
eye to drain the fluid out. This is a technically difficult
and complicated procedure and rarely done. Just recently
a new drainage procedure has been developed that is less
invasive than a trabeculectomy. This is known as a canalicular
viscocanulostomy. The early results look promising but only
time will tell whether this takes over as the procedure
of choice.
The use of marijuana in the treatment of glaucoma
There is evidence that the use of marijuana (or its components)
taken orally or by inhalation can lower the intraocular
pressure. There are however no conclusive studies to date
to indicate that marijuana can safely and effectively lower
intraocular pressure enough to prevent optic nerve damage.
A long-term clinical study is required to test the safety
and efficacy of marijuana.
|